These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A case of femoral diaphyseal fracture after long-term treatment with zoledronic acid. Ishizuna K; Ota D; Fukuuchi A; Teraoka M; Fujii A; Mori M; Nishi T Breast Cancer; 2015 Jan; 22(1):90-4. PubMed ID: 22009549 [TBL] [Abstract][Full Text] [Related]
3. Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence? Reddy SV; Gupta SK Singapore Med J; 2012 Mar; 53(3):e52-4. PubMed ID: 22434305 [TBL] [Abstract][Full Text] [Related]
4. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report. Park KT; Lee KB Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188 [TBL] [Abstract][Full Text] [Related]
5. Can long-term bisphosphonate use causes low-energy fractures? A case report. Dandinoğlu T; Akarsu S; Karadeniz M; Tekin L; Arıbal S; Kıralp MZ Osteoporos Int; 2014 Feb; 25(2):773-6. PubMed ID: 23824297 [TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates. Sánchez A; Blanco R Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217 [TBL] [Abstract][Full Text] [Related]
7. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures. Phillips HK; Harrison SJ; Akrawi H; Sidhom SA Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753 [TBL] [Abstract][Full Text] [Related]
8. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures. Righetti M; Wach J; Desmarchelier R; Coury F Joint Bone Spine; 2018 May; 85(3):365-367. PubMed ID: 29246529 [TBL] [Abstract][Full Text] [Related]
9. Bilateral simultaneous femoral diaphyseal fractures in a patient with long-term ibandronate use. Patel VC; Lazzarini AM Orthopedics; 2010 Oct; 33(10):775. PubMed ID: 20954650 [TBL] [Abstract][Full Text] [Related]
10. Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management. Koh A; Guerado E; Giannoudis PV Bone Joint J; 2017 Mar; 99-B(3):295-302. PubMed ID: 28249967 [TBL] [Abstract][Full Text] [Related]
11. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. Kim SY; Schneeweiss S; Katz JN; Levin R; Solomon DH J Bone Miner Res; 2011 May; 26(5):993-1001. PubMed ID: 21542002 [TBL] [Abstract][Full Text] [Related]
12. ATYPICAL FEMORAL FRACTURES AFTER LONG-TERM BISPHOSPHONATES THERAPY: CASE REPORT. Găleşanu C; Mocanu V; Buzdugă C; Florescu A; Zaharia V; Lisnic V Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):114-8. PubMed ID: 27125082 [TBL] [Abstract][Full Text] [Related]
13. Going on a drug holiday? Bonnick SL J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091 [No Abstract] [Full Text] [Related]
14. The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years. Haschka J; Kühne F; Muschitz C; Pirker T; Kocijan R; Bittighofer C; Trubrich A; Resch H Wien Klin Wochenschr; 2011 Nov; 123(21-22):684-7. PubMed ID: 21837437 [TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-associated atypical femur fracture in a 90-year-old Caucasian woman. Gopinath KG; Shibu PK Hong Kong Med J; 2015 Jun; 21(3):286.e2-3. PubMed ID: 26045077 [No Abstract] [Full Text] [Related]
16. Diagnosis of proximal femoral insufficiency fractures in patients receiving bisphosphonate therapy. Porrino JA; Kohl CA; Taljanovic M; Rogers LF AJR Am J Roentgenol; 2010 Apr; 194(4):1061-4. PubMed ID: 20308511 [TBL] [Abstract][Full Text] [Related]
17. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Lenart BA; Neviaser AS; Lyman S; Chang CC; Edobor-Osula F; Steele B; van der Meulen MC; Lorich DG; Lane JM Osteoporos Int; 2009 Aug; 20(8):1353-62. PubMed ID: 19066707 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous non-traumatic stress fractures in bilateral femoral shafts in a patient treated with bisphosphonates. Shin DY; Ku CR; Kim KM; Choi HS; Rhee Y; Lee EJ; Lim SK Korean J Intern Med; 2012 Mar; 27(1):98-102. PubMed ID: 22403507 [TBL] [Abstract][Full Text] [Related]
19. Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series. Sasaki S; Miyakoshi N; Hongo M; Kasukawa Y; Shimada Y J Bone Miner Metab; 2012 Sep; 30(5):561-7. PubMed ID: 22610061 [TBL] [Abstract][Full Text] [Related]
20. Yearly zoledronic acid in postmenopausal osteoporosis. Chang JT N Engl J Med; 2007 Aug; 357(7):713-4; author reply 714-5. PubMed ID: 17703528 [No Abstract] [Full Text] [Related] [Next] [New Search]